These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 24117733)
21. Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine-rich repeat kinase 2. Caesar M; Felk S; Zach S; Brønstad G; Aasly JO; Gasser T; Gillardon F Glia; 2014 Jul; 62(7):1075-92. PubMed ID: 24652679 [TBL] [Abstract][Full Text] [Related]
24. MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. Fell MJ; Mirescu C; Basu K; Cheewatrakoolpong B; DeMong DE; Ellis JM; Hyde LA; Lin Y; Markgraf CG; Mei H; Miller M; Poulet FM; Scott JD; Smith MD; Yin Z; Zhou X; Parker EM; Kennedy ME; Morrow JA J Pharmacol Exp Ther; 2015 Dec; 355(3):397-409. PubMed ID: 26407721 [TBL] [Abstract][Full Text] [Related]
25. Genetic dissection reveals that Akt is the critical kinase downstream of LRRK2 to phosphorylate and inhibit FOXO1, and promotes neuron survival. Chuang CL; Lu YN; Wang HC; Chang HY Hum Mol Genet; 2014 Nov; 23(21):5649-58. PubMed ID: 24916379 [TBL] [Abstract][Full Text] [Related]
35. LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations. Ohta E; Kawakami F; Kubo M; Obata F FEBS Lett; 2011 Jul; 585(14):2165-70. PubMed ID: 21658387 [TBL] [Abstract][Full Text] [Related]
36. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy. Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Su YC; Qi X Hum Mol Genet; 2013 Nov; 22(22):4545-61. PubMed ID: 23813973 [TBL] [Abstract][Full Text] [Related]
38. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders. Puccini JM; Marker DF; Fitzgerald T; Barbieri J; Kim CS; Miller-Rhodes P; Lu SM; Dewhurst S; Gelbard HA J Neurosci; 2015 Apr; 35(13):5271-83. PubMed ID: 25834052 [TBL] [Abstract][Full Text] [Related]
39. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation. Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768 [TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of LRRK2: from kinase to substrate. Lobbestael E; Baekelandt V; Taymans JM Biochem Soc Trans; 2012 Oct; 40(5):1102-10. PubMed ID: 22988873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]